Component,Publication Grant Number,Publication Doi,Publication Journal,Pubmed Id,Pubmed Url,Publication Title,Publication Year,Publication Keywords,Publication Authors,Publication Abstract,Publication Assay,Publication Tumor Type,Publication Tissue,Publication Dataset Alias,Publication Accessibility,PublicationView_id,Id,entityId
PublicationView,CA250046,10.1038/s41375-024-02142-9,Leukemia,38307941,https://pubmed.ncbi.nlm.nih.gov/38307941,State-transition modeling of blood transcriptome predicts disease evolution and treatment response in chronic myeloid leukemia,2024,,"David E Frankhouser, Russell C Rockne, Lisa Uechi, Dandan Zhao, Sergio Branciamore, Denis O'Meally, Jihyun Irizarry, Lucy Ghoda, Haris Ali, Jeffery M Trent, Stephen Forman, Yu-Hsuan Fu, Ya-Huei Kuo, Bin Zhang, Guido Marcucci","Chronic myeloid leukemia (CML) is initiated and maintained by BCR::ABL which is clinically targeted using tyrosine kinase inhibitors (TKIs). TKIs can induce long-term remission but are also not curative. Thus, CML is an ideal system to test our hypothesis that transcriptome-based state-transition models accurately predict cancer evolution and treatment response. We collected time-sequential blood (Read more on Pubmed)","RNA Sequencing, Mathematical Modeling",Chronic Myeloid Leukemia         ,Blood,Not Applicable,Open Access,38307941,ef11ecb7-2d84-4549-9fc2-463de6b5092b,syn52566225
